This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes.
|Tradename||Indication for Use||NDA Number||Applicant||Approval Date|
|Anticoagulant Sodium Citrate 4% Solution||Is indicated for use only for the anticoagulation of whole blood as part of automated apheresis procedures||125750/0||CSL Plasma, Inc.
155 Medical Sciences Drive
Union, SC 29379